Translocation (X;20) involving the inactive X chromosome in a patient with myeloproliferative disorder.

Cancer Genet Cytogenet

Department of Haematology, Royal Perth Hospital, GPO Box X2213, Perth, Western Australia 6847.

Published: April 2005

We report a patient with an unclassifiable myeloproliferative disorder and the rare t(X;20)(q13;q13.3) as the sole cytogenetic abnormality. The breakpoint on Xq is consistent with other reports of translocations involving the X chromosome with breakpoints that cluster to Xq13 and association with myeloid disorders. Late replication studies demonstrated the inactive X chromosome was involved in this translocation. The critical event in patients with myeloproliferative disease and deletion of 20q appears to be the loss of tumor suppressor genes. This may also be the mechanism in this patient with a potential cryptic deletion associated with the translocation. Alternatively, spreading of X inactivation into the derivative chromosome 20 provides a second mechanism for the loss of function of tumor suppressor genes on 20q. The finding in this patient of t(X;20) together with three others reported in the literature indicates that this may represent a primary non-random abnormality associated with myeloid malignancy, which may take on clinical significance with the accumulation of more cases.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cancergencyto.2004.08.029DOI Listing

Publication Analysis

Top Keywords

inactive chromosome
8
myeloproliferative disorder
8
tumor suppressor
8
suppressor genes
8
translocation x20
4
x20 involving
4
involving inactive
4
chromosome
4
patient
4
chromosome patient
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!